维普中文期刊产品整合服务
125篇 您的检索式:作者名="Tesar V"
    题名 作者 年代 出处 被引量
1Soluble adhesion molecules and cytokines in patients with myasthenmia gravis treater by plasma exchange显示文摘Tesar V Jel Inkova E M jiras JR 2010Blood Purif2010,18,2:1
2Protein turnover by the proteasome in aging and disease 显示文摘Kalousova M Zima T Tesar V 2002Fee Radic Biol Med2002,32,11:1
3Cytokines and adhesion molocules in renal vasculitis and lupus nephritis 显示文摘Tesar V Masek Z Ryehlik I 1998Nephrol Dial Transplant1998,13,7:1
4Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background 显示文摘KALOUSOVA M ZIMA T TESAR V 2005Mutat Res2005,579,12:1
5Current treatment strategies in ANCA-positive renalvasculitis-lessons from European randomized trials显示文摘Tesar V Rihova Z Jancova E 2003Nephrol Dial Transplant2003,18,5:1
6Relationship between advanced glycoxidation end products,inflammatory markers/acute-phase reactants,and some autoantibodies in chronic hemodialysis patients显示文摘 Zima T Tesar V 2003Kidney Int Suppl2003,84,:1
7The Czech registry of renal biopsies:Occurrence of renal diseases in the years 1994-2000显示文摘Rychlik I Jancova E Tesar V 2004Nephrol Dial Transplant2004,19,12:1
8Adhesion molecules and cytokines in vasculitides显示文摘Fucikora T Tesar V Masek J 1995Bratisl Lek Listy1995,96,10:1
9Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease显示文摘Rysava R Tesar V Merta M 2005Blood press Monit2005,10,4:1
10Diagnostic and pathogenetic role of antineutrophil cytoplasmic autoantibodies显示文摘BARTUNKOVA J TESAR V SEDIVA A 2003Clin Immunol2003,106,:1
11Pump for Extremely Dangerous Liquids 显示文摘Tesar V 2011JChemical Engineering Research and Design2011,,:1
12Microbubble generation显示文摘Zimmerman W B Tesar V Butler S 2008Recent Patents on Engineering2008,,:1
13Advanced glycation end products and advanced oxidation protein products in hemodialyzed patients显示文摘Kalousova M Zima T Tesar V 2002Blood Purff2002,20,:1
14Advanced glycation end products and advanced oxidation protein products in hemodialyzed patients显示文摘Kalousova M Zima T Tesar V 2002Blood Purif2002,20,6:1
15The past, the present and the future of renal replacement thera- py 显示文摘Tesar V 2011Vnitr Lek2011,57,78:1
16Relationship between advanced glycoxidation end products, inflammatory markers/acutephase reactants, and some autoantibodies in chronic hemodialysis patients 显示文摘Kalousova M Zima T Tesar V 2003Kidney Int Suppl2003,,:1
17Association of advanced vaseulopathy and transforming growth factor-beta1 gene expres- sion with immunoglobulin A nephropathy progression显示文摘Brabeova I Tesar V Honsova E 2011Neph- rol Dial Transplant2011,26,2:1
18Cytokines and adhesion molecules in renal vaseulitis and lupus nephritis 显示文摘Tesar V Masek Z Rychlik l 1998Nephrol Dial Transplant1998,13,17:1
19The past,the present and the future of renal replacement therapy显示文摘Tesar V 2011Vnitr Lek2011,57,78:1
20Proteinuria and hypertension in patients treated with inhibitors of the VEGF signalling pathway-inci- dence, mechanisms and management显示文摘Tesarova P Tesar V 2013Folia Biol (Praha)2013,59,1:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费